Marshall Wace North America’s Morphic Holding, Inc. Common Stock MORF Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2021
Q3
$31.2M Sell
550,637
-28,900
-5% -$1.75M 0.13% 176
2021
Q2
$33.3M Sell
579,537
-4,105
-0.7% -$226K 0.14% 154
2021
Q1
$36.9M Buy
583,642
+447,822
+330% +$20.6M 0.15% 157
2020
Q4
$4.56M Buy
135,820
+59,454
+78% +$1.76M 0.02% 563
2020
Q3
$2.09M Hold
76,366
0.01% 572
2020
Q2
$2.07M Hold
76,366
0.01% 587
2020
Q1
$1.12M Hold
76,366
0.01% 597
2019
Q4
$1.31M Hold
76,366
0.01% 667
2019
Q3
$1.38M Sell
76,366
-31,408
-29% -$658K 0.01% 625
2019
Q2
$2.14M Buy
+107,774
New +$2.04M 0.01% 548

Other funds holding MORF

Marshall Wace North America's MORF Position: Q3 2021 in Review

Marshall Wace North America reduced its Morphic Holding, Inc. Common Stock (MORF) stake by 5% in Q3 2021, selling an estimated $1.75M and leaving 550,637 shares worth $31.2M. The position accounts for 0.13% of the portfolio, ranked #176.

Marshall Wace North America first reported a position in MORF in Q2 2019 and has held it in 10 quarters since. The position peaked at $36.9M in Q1 2021. 110 funds tracked by Wall St. Rank hold MORF as of Q3 2021.

  • Marshall Wace North America held 550,637 shares of Morphic Holding, Inc. Common Stock worth $31.2M as of Q3 2021.
  • Marshall Wace North America sold 28,900 Morphic Holding, Inc. Common Stock shares in Q3 2021, an estimated $1.75M.
  • Morphic Holding, Inc. Common Stock made up 0.13% of Marshall Wace North America's portfolio in Q3 2021, its #176 holding.
  • Marshall Wace North America first reported a position in Morphic Holding, Inc. Common Stock in Q2 2019 and has held it in 10 quarters since.
  • Marshall Wace North America's Morphic Holding, Inc. Common Stock position peaked at $36.9M in Q1 2021.
  • 110 funds tracked by Wall St. Rank held Morphic Holding, Inc. Common Stock as of Q3 2021.

Based on Marshall Wace North America's 13F filing for Q3 2021, filed 15 Nov 2021.